Key Takeaways OPRX posted 11% revenue growth and $1.5M adjusted EBITDA, its best Q1 showing to date. 80% of OPRX's FY25 revenue guidance is covered by contracts; subscription share exceeds 5%. OPRX's Gross margin dipped to 60.9% as a lower-margin DTC mix weighed on profitability.OptimizeRx (OPRX) kicked off 2025 with strong momentum, delivering 11% year-over-year revenue growth to $21.9 million and turning in $1.5 million in adjusted EBITDA, its strongest first-quarter performance to date. The digital hea ...